# Monitoring cognition in multiple sclerosis via adaptive smartphone games—first insights from a validation study

**Authors:** Silvan Pless, Tim Woelfle, Johannes Lorscheider, Andrea Wiencierz, Óscar Reyes, Carlos Luque, Pasquale Calabrese, Cristina Granziera, Ludwig Kappos

PMC · DOI: 10.3389/fdgth.2026.1627226 · Frontiers in Digital Health · 2026-02-10

## TL;DR

Researchers developed CoGames, a set of smartphone games to monitor cognition in people with multiple sclerosis, showing promising reliability and user adherence.

## Contribution

The study introduces CoGames, a novel set of adaptive and gamified smartphone tests for cognitive monitoring in multiple sclerosis.

## Key findings

- Test-retest correlations for CoGames ranged from r = 0.41 to 0.91, indicating strong reliability.
- Game measures correlated with reference tests (|ρ| = 0.23 to 0.66), supporting their validity.
- User adherence to the games was high at 89.3%, highlighting the benefits of gamification.

## Abstract

Cognitive impairment in Multiple Sclerosis significantly undermines quality of life and working capacity yet despite its high prevalence (30%–75%) it is often neglected. Gamified and adaptive smartphone tests have great potential to assess cognition reliably and conveniently. To improve monitoring of cognition in people with MS (pwMS) we developed CoGames, a set of 6 adaptive and gamified smartphone tests. Here we present first insights into their reliability, correlations to domain-corresponding reference tests, and adherence. The games were played repeatedly over 6 weeks. We calculated correlation estimates between game-derived measures of the first two runs for the test-retest reliability analysis, correlated (partial Spearman correlation) game measures with the results of established reference tests and assessed adherence as the proportion of played- to scheduled games. We included data collected between March 2022 and October 2023 of the first 100 pwMS, mean age: 46.8 (±12.3), median EDSS: 2.5 (0–7.0), who completed the initial intensive phase of the dreaMS validation study 1 (NCT05009160). Test-retest correlation estimates ranged from r = 0.41 to 0.91. Correlation estimates to reference tests ranged from |ρ| = 0.23 to 0.66. Average adherence was 89.3% (86%–92%). Our results suggest high test-retest reliability of the CoGames and clear correlations with their reference tests. Adherence was higher than for other tests included in the dreaMS app underlining the value of gamification. Albeit these results must be confirmed in a larger population over a longer time, they support the potential of CoGames as a valid, reliable and enjoyable monitoring-tool for cognition in pwMS.

## Linked entities

- **Diseases:** Multiple Sclerosis (MONDO:0005301)

## Full-text entities

- **Genes:** AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}
- **Diseases:** CL (MESH:D002971), fine- (MESH:D014202), cardiovascular disease (MESH:D002318), pwMS (MESH:C000719191), IPS (MESH:D010335), MS (MESH:D009103), Cognitive impairment (MESH:D003072), inflammatory (MESH:D007249), hepatic dysfunction (MESH:D008107), neurodegenerative auto-immune disease (MESH:D019636), somatosensory dysfunctions (MESH:D020886), cancer (MESH:D009369), HD (MESH:D006816), renal failure (MESH:D051437), cognitive fatigue (MESH:D005221)
- **Chemicals:** lrhol (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12930360/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12930360/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12930360/full.md

---
Source: https://tomesphere.com/paper/PMC12930360